Long–Term Effectiveness of Sacral Nerve Stimulation for Refractory Urge Incontinence

Objectives: To evaluate the long–term efficacy of sacral nerve stimulation for refractory urinary urge incontinence. Study Design and Methods: Urge incontinent patients qualified for surgical implantation of a neurostimulator system after trial screening with percutaneous test stimulation. Surgical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European urology 2001-01, Vol.39 (1), p.101-106
Hauptverfasser: Janknegt, Ruud A., Hassouna, Magdy M., Siegel, Steven W., Schmidt, Richard A., Gajewski, Jerzy B., Rivas, David A., Elhilali, Mostafa M., Milam, Douglas C., van Kerrebroeck, Philip E.V., Dijkema, Hero E., Lycklama à Nÿeholt, A.A.B., Fall, Magnus, Jonas, Udo, Catanzaro, Francesco, Fowler, Clare J., Oleson, Kimbery A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106
container_issue 1
container_start_page 101
container_title European urology
container_volume 39
creator Janknegt, Ruud A.
Hassouna, Magdy M.
Siegel, Steven W.
Schmidt, Richard A.
Gajewski, Jerzy B.
Rivas, David A.
Elhilali, Mostafa M.
Milam, Douglas C.
van Kerrebroeck, Philip E.V.
Dijkema, Hero E.
Lycklama à Nÿeholt, A.A.B.
Fall, Magnus
Jonas, Udo
Catanzaro, Francesco
Fowler, Clare J.
Oleson, Kimbery A.
description Objectives: To evaluate the long–term efficacy of sacral nerve stimulation for refractory urinary urge incontinence. Study Design and Methods: Urge incontinent patients qualified for surgical implantation of a neurostimulator system after trial screening with percutaneous test stimulation. Surgical implantation of the InterStim System (Medtronic Inc., Minneapolis, Minn., USA) was performed in cases where a >50% reduction in incontinence symptoms was documented during the 3– to 7–day test stimulation period. The InterStim System consists of an implantable pulse generator, a transforamenally placed quadripolar lead, and an extension that connects these two devices for unilateral stimulation of the S3 or S4 sacral nerve. Efficacy for 96 implanted patients was based on urinary symptom changes as quantified in voiding diaries collected at baseline and annually after surgical implantation. Results: As compared to baseline, the group of 96 implanted patients demonstrated significant reductions in urge incontinent symptoms at an average of 30.8±14.8 (range 12–60) months with respect to the number of urge incontinent episodes per day, severity of leaking, and the number of absorbent pads/diapers replaced per day due to incontinence (all p
doi_str_mv 10.1159/000052420
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_11173947</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70628697</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-5b333943782b4a09dbc83ac0a311f44bee0b482340ae9da41996e049b5e8cf23</originalsourceid><addsrcrecordid>eNpt0MtKAzEUgOEgiq2XhWtBgoLgYjS36SRLkXqBomBbt0MmPSmjM0lNpgV3voNv6JM42lo3ZpPF-TgJP0IHlJxTmqoL0p6UCUY2UJfKjCdZ2iObqEs4YQmTXHbQTozPreKp4tuoQynNuBJZFz0NvJt-vn-MINS4by2YplyAgxixt3ioTdAVvoewADxsynpe6ab0Dlsf8CPYoE3jwxsehyngO2e8a0oHzsAe2rK6irC_unfR6Lo_urpNBg83d1eXg8TwVDZJWnDe_oNnkhVCEzUpjOTaEM0ptUIUAKQQknFBNKiJFlSpHhChihSksYzvotPl2lnwr3OITV6X0UBVaQd-HvOM9JjsqayFZ0togo8xgM1noax1eMspyb8b5uuGrT1aLZ0XNUz-5CpaC05WQEejq7aCM2VcO5kRRr7V4VK96LZOWI9_Hzn-d9ofP_6AfDax_Av7g413</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70628697</pqid></control><display><type>article</type><title>Long–Term Effectiveness of Sacral Nerve Stimulation for Refractory Urge Incontinence</title><source>MEDLINE</source><source>Karger Journals</source><creator>Janknegt, Ruud A. ; Hassouna, Magdy M. ; Siegel, Steven W. ; Schmidt, Richard A. ; Gajewski, Jerzy B. ; Rivas, David A. ; Elhilali, Mostafa M. ; Milam, Douglas C. ; van Kerrebroeck, Philip E.V. ; Dijkema, Hero E. ; Lycklama à Nÿeholt, A.A.B. ; Fall, Magnus ; Jonas, Udo ; Catanzaro, Francesco ; Fowler, Clare J. ; Oleson, Kimbery A.</creator><creatorcontrib>Janknegt, Ruud A. ; Hassouna, Magdy M. ; Siegel, Steven W. ; Schmidt, Richard A. ; Gajewski, Jerzy B. ; Rivas, David A. ; Elhilali, Mostafa M. ; Milam, Douglas C. ; van Kerrebroeck, Philip E.V. ; Dijkema, Hero E. ; Lycklama à Nÿeholt, A.A.B. ; Fall, Magnus ; Jonas, Udo ; Catanzaro, Francesco ; Fowler, Clare J. ; Oleson, Kimbery A.</creatorcontrib><description>Objectives: To evaluate the long–term efficacy of sacral nerve stimulation for refractory urinary urge incontinence. Study Design and Methods: Urge incontinent patients qualified for surgical implantation of a neurostimulator system after trial screening with percutaneous test stimulation. Surgical implantation of the InterStim System (Medtronic Inc., Minneapolis, Minn., USA) was performed in cases where a &gt;50% reduction in incontinence symptoms was documented during the 3– to 7–day test stimulation period. The InterStim System consists of an implantable pulse generator, a transforamenally placed quadripolar lead, and an extension that connects these two devices for unilateral stimulation of the S3 or S4 sacral nerve. Efficacy for 96 implanted patients was based on urinary symptom changes as quantified in voiding diaries collected at baseline and annually after surgical implantation. Results: As compared to baseline, the group of 96 implanted patients demonstrated significant reductions in urge incontinent symptoms at an average of 30.8±14.8 (range 12–60) months with respect to the number of urge incontinent episodes per day, severity of leaking, and the number of absorbent pads/diapers replaced per day due to incontinence (all p&lt;0.0001, respectively). Gender, pretreatment variables, and age were not found to be relevant factors that affected these results. 11 of the 96 patients underwent device explant due to lack of efficacy, pain or bowel dysfunction. These data were conservatively included in the efficacy results. No permanent injuries associated with the devices or therapy were reported. Conclusion: Sacral nerve stimulation is an effective treatment for refractory urge incontinence with sustained long–term benefit through an average of 30.8 months.</description><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>EISSN: 1421-993X</identifier><identifier>DOI: 10.1159/000052420</identifier><identifier>PMID: 11173947</identifier><identifier>CODEN: EUURAV</identifier><language>eng</language><publisher>Basel, Switzerland: Elsevier</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Diseases of the urinary system ; Electric Stimulation Therapy ; Female ; Humans ; Lumbosacral Plexus ; Male ; Medical sciences ; Middle Aged ; Neurourology ; Prospective Studies ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Time Factors ; Urinary Incontinence - therapy</subject><ispartof>European urology, 2001-01, Vol.39 (1), p.101-106</ispartof><rights>2000 S. Karger AG, Basel</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-5b333943782b4a09dbc83ac0a311f44bee0b482340ae9da41996e049b5e8cf23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,2423,4010,27904,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=870207$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11173947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Janknegt, Ruud A.</creatorcontrib><creatorcontrib>Hassouna, Magdy M.</creatorcontrib><creatorcontrib>Siegel, Steven W.</creatorcontrib><creatorcontrib>Schmidt, Richard A.</creatorcontrib><creatorcontrib>Gajewski, Jerzy B.</creatorcontrib><creatorcontrib>Rivas, David A.</creatorcontrib><creatorcontrib>Elhilali, Mostafa M.</creatorcontrib><creatorcontrib>Milam, Douglas C.</creatorcontrib><creatorcontrib>van Kerrebroeck, Philip E.V.</creatorcontrib><creatorcontrib>Dijkema, Hero E.</creatorcontrib><creatorcontrib>Lycklama à Nÿeholt, A.A.B.</creatorcontrib><creatorcontrib>Fall, Magnus</creatorcontrib><creatorcontrib>Jonas, Udo</creatorcontrib><creatorcontrib>Catanzaro, Francesco</creatorcontrib><creatorcontrib>Fowler, Clare J.</creatorcontrib><creatorcontrib>Oleson, Kimbery A.</creatorcontrib><title>Long–Term Effectiveness of Sacral Nerve Stimulation for Refractory Urge Incontinence</title><title>European urology</title><addtitle>Eur Urol</addtitle><description>Objectives: To evaluate the long–term efficacy of sacral nerve stimulation for refractory urinary urge incontinence. Study Design and Methods: Urge incontinent patients qualified for surgical implantation of a neurostimulator system after trial screening with percutaneous test stimulation. Surgical implantation of the InterStim System (Medtronic Inc., Minneapolis, Minn., USA) was performed in cases where a &gt;50% reduction in incontinence symptoms was documented during the 3– to 7–day test stimulation period. The InterStim System consists of an implantable pulse generator, a transforamenally placed quadripolar lead, and an extension that connects these two devices for unilateral stimulation of the S3 or S4 sacral nerve. Efficacy for 96 implanted patients was based on urinary symptom changes as quantified in voiding diaries collected at baseline and annually after surgical implantation. Results: As compared to baseline, the group of 96 implanted patients demonstrated significant reductions in urge incontinent symptoms at an average of 30.8±14.8 (range 12–60) months with respect to the number of urge incontinent episodes per day, severity of leaking, and the number of absorbent pads/diapers replaced per day due to incontinence (all p&lt;0.0001, respectively). Gender, pretreatment variables, and age were not found to be relevant factors that affected these results. 11 of the 96 patients underwent device explant due to lack of efficacy, pain or bowel dysfunction. These data were conservatively included in the efficacy results. No permanent injuries associated with the devices or therapy were reported. Conclusion: Sacral nerve stimulation is an effective treatment for refractory urge incontinence with sustained long–term benefit through an average of 30.8 months.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Diseases of the urinary system</subject><subject>Electric Stimulation Therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Lumbosacral Plexus</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neurourology</subject><subject>Prospective Studies</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Time Factors</subject><subject>Urinary Incontinence - therapy</subject><issn>0302-2838</issn><issn>1873-7560</issn><issn>1421-993X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0MtKAzEUgOEgiq2XhWtBgoLgYjS36SRLkXqBomBbt0MmPSmjM0lNpgV3voNv6JM42lo3ZpPF-TgJP0IHlJxTmqoL0p6UCUY2UJfKjCdZ2iObqEs4YQmTXHbQTozPreKp4tuoQynNuBJZFz0NvJt-vn-MINS4by2YplyAgxixt3ioTdAVvoewADxsynpe6ab0Dlsf8CPYoE3jwxsehyngO2e8a0oHzsAe2rK6irC_unfR6Lo_urpNBg83d1eXg8TwVDZJWnDe_oNnkhVCEzUpjOTaEM0ptUIUAKQQknFBNKiJFlSpHhChihSksYzvotPl2lnwr3OITV6X0UBVaQd-HvOM9JjsqayFZ0togo8xgM1noax1eMspyb8b5uuGrT1aLZ0XNUz-5CpaC05WQEejq7aCM2VcO5kRRr7V4VK96LZOWI9_Hzn-d9ofP_6AfDax_Av7g413</recordid><startdate>200101</startdate><enddate>200101</enddate><creator>Janknegt, Ruud A.</creator><creator>Hassouna, Magdy M.</creator><creator>Siegel, Steven W.</creator><creator>Schmidt, Richard A.</creator><creator>Gajewski, Jerzy B.</creator><creator>Rivas, David A.</creator><creator>Elhilali, Mostafa M.</creator><creator>Milam, Douglas C.</creator><creator>van Kerrebroeck, Philip E.V.</creator><creator>Dijkema, Hero E.</creator><creator>Lycklama à Nÿeholt, A.A.B.</creator><creator>Fall, Magnus</creator><creator>Jonas, Udo</creator><creator>Catanzaro, Francesco</creator><creator>Fowler, Clare J.</creator><creator>Oleson, Kimbery A.</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200101</creationdate><title>Long–Term Effectiveness of Sacral Nerve Stimulation for Refractory Urge Incontinence</title><author>Janknegt, Ruud A. ; Hassouna, Magdy M. ; Siegel, Steven W. ; Schmidt, Richard A. ; Gajewski, Jerzy B. ; Rivas, David A. ; Elhilali, Mostafa M. ; Milam, Douglas C. ; van Kerrebroeck, Philip E.V. ; Dijkema, Hero E. ; Lycklama à Nÿeholt, A.A.B. ; Fall, Magnus ; Jonas, Udo ; Catanzaro, Francesco ; Fowler, Clare J. ; Oleson, Kimbery A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-5b333943782b4a09dbc83ac0a311f44bee0b482340ae9da41996e049b5e8cf23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Diseases of the urinary system</topic><topic>Electric Stimulation Therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Lumbosacral Plexus</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neurourology</topic><topic>Prospective Studies</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Time Factors</topic><topic>Urinary Incontinence - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Janknegt, Ruud A.</creatorcontrib><creatorcontrib>Hassouna, Magdy M.</creatorcontrib><creatorcontrib>Siegel, Steven W.</creatorcontrib><creatorcontrib>Schmidt, Richard A.</creatorcontrib><creatorcontrib>Gajewski, Jerzy B.</creatorcontrib><creatorcontrib>Rivas, David A.</creatorcontrib><creatorcontrib>Elhilali, Mostafa M.</creatorcontrib><creatorcontrib>Milam, Douglas C.</creatorcontrib><creatorcontrib>van Kerrebroeck, Philip E.V.</creatorcontrib><creatorcontrib>Dijkema, Hero E.</creatorcontrib><creatorcontrib>Lycklama à Nÿeholt, A.A.B.</creatorcontrib><creatorcontrib>Fall, Magnus</creatorcontrib><creatorcontrib>Jonas, Udo</creatorcontrib><creatorcontrib>Catanzaro, Francesco</creatorcontrib><creatorcontrib>Fowler, Clare J.</creatorcontrib><creatorcontrib>Oleson, Kimbery A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Janknegt, Ruud A.</au><au>Hassouna, Magdy M.</au><au>Siegel, Steven W.</au><au>Schmidt, Richard A.</au><au>Gajewski, Jerzy B.</au><au>Rivas, David A.</au><au>Elhilali, Mostafa M.</au><au>Milam, Douglas C.</au><au>van Kerrebroeck, Philip E.V.</au><au>Dijkema, Hero E.</au><au>Lycklama à Nÿeholt, A.A.B.</au><au>Fall, Magnus</au><au>Jonas, Udo</au><au>Catanzaro, Francesco</au><au>Fowler, Clare J.</au><au>Oleson, Kimbery A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long–Term Effectiveness of Sacral Nerve Stimulation for Refractory Urge Incontinence</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2001-01</date><risdate>2001</risdate><volume>39</volume><issue>1</issue><spage>101</spage><epage>106</epage><pages>101-106</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><eissn>1421-993X</eissn><coden>EUURAV</coden><abstract>Objectives: To evaluate the long–term efficacy of sacral nerve stimulation for refractory urinary urge incontinence. Study Design and Methods: Urge incontinent patients qualified for surgical implantation of a neurostimulator system after trial screening with percutaneous test stimulation. Surgical implantation of the InterStim System (Medtronic Inc., Minneapolis, Minn., USA) was performed in cases where a &gt;50% reduction in incontinence symptoms was documented during the 3– to 7–day test stimulation period. The InterStim System consists of an implantable pulse generator, a transforamenally placed quadripolar lead, and an extension that connects these two devices for unilateral stimulation of the S3 or S4 sacral nerve. Efficacy for 96 implanted patients was based on urinary symptom changes as quantified in voiding diaries collected at baseline and annually after surgical implantation. Results: As compared to baseline, the group of 96 implanted patients demonstrated significant reductions in urge incontinent symptoms at an average of 30.8±14.8 (range 12–60) months with respect to the number of urge incontinent episodes per day, severity of leaking, and the number of absorbent pads/diapers replaced per day due to incontinence (all p&lt;0.0001, respectively). Gender, pretreatment variables, and age were not found to be relevant factors that affected these results. 11 of the 96 patients underwent device explant due to lack of efficacy, pain or bowel dysfunction. These data were conservatively included in the efficacy results. No permanent injuries associated with the devices or therapy were reported. Conclusion: Sacral nerve stimulation is an effective treatment for refractory urge incontinence with sustained long–term benefit through an average of 30.8 months.</abstract><cop>Basel, Switzerland</cop><pub>Elsevier</pub><pmid>11173947</pmid><doi>10.1159/000052420</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0302-2838
ispartof European urology, 2001-01, Vol.39 (1), p.101-106
issn 0302-2838
1873-7560
1421-993X
language eng
recordid cdi_pubmed_primary_11173947
source MEDLINE; Karger Journals
subjects Adult
Aged
Biological and medical sciences
Diseases of the urinary system
Electric Stimulation Therapy
Female
Humans
Lumbosacral Plexus
Male
Medical sciences
Middle Aged
Neurourology
Prospective Studies
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Time Factors
Urinary Incontinence - therapy
title Long–Term Effectiveness of Sacral Nerve Stimulation for Refractory Urge Incontinence
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A06%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long%E2%80%93Term%20Effectiveness%20of%20Sacral%20Nerve%20Stimulation%20for%20Refractory%20Urge%20Incontinence&rft.jtitle=European%20urology&rft.au=Janknegt,%20Ruud%20A.&rft.date=2001-01&rft.volume=39&rft.issue=1&rft.spage=101&rft.epage=106&rft.pages=101-106&rft.issn=0302-2838&rft.eissn=1873-7560&rft.coden=EUURAV&rft_id=info:doi/10.1159/000052420&rft_dat=%3Cproquest_pubme%3E70628697%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70628697&rft_id=info:pmid/11173947&rfr_iscdi=true